Type 2 diabetes, obesity, and metabolic syndrome (hereafter referred to as “diabesity”) associated with increased insulin resistance and/or decreased insulin sensitivity have also been implicated with mitochondrial dysfunction and alterations in energy metabolism. The gene discussed is INS; the disease is metabolic syndrome.